Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 04/30/16
Due: 04/30/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of Metabolic Profile of OC000459 | NCT02341521 | Atopix Therapeutics, Ltd. | user2@example.com | None | 2015-03-31 | 2015-05-31 | 2016-05-31 | - | - | 2025-07-14 |
| Effect of OC000459 on Moderate to Severe Atopic Dermatitis | NCT02002208 | Atopix Therapeutics, Ltd. | user2@example.com | None | 2013-10-31 | 2016-02-29 | 2017-02-28 | - | - | 2025-07-14 |
| First in Man Evaluation of Single and Multiple Doses of Oral ATX2417 | NCT02316912 | Atopix Therapeutics, Ltd. | user2@example.com | None | 2015-02-28 | 2016-04-30 | 2017-04-30 | - | - | 2025-07-14 |